| scholarly article | Q13442814 |
| P2093 | author name string | Jun Kunisawa | |
| Masuo Kondoh | |||
| Hidehiko Suzuki | |||
| Koji Hosomi | |||
| Ayaka Nasu | |||
| P2860 | cites work | Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands | Q22008687 |
| Humoral Immunity Due to Long-Lived Plasma Cells | Q52040025 | ||
| Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4. | Q52565720 | ||
| Transcutaneous delivery of tetanus toxin Hc fragment induces superior tetanus toxin neutralizing antibody response compared to tetanus toxoid | Q53444861 | ||
| Characteristics of claudin expression in follicle-associated epithelium of Peyer's patches: preferential localization of claudin-4 at the apex of the dome region. | Q54764575 | ||
| Cholera | Q55890255 | ||
| Identification of an immunodominant T cell epitope on cholera toxin | Q57197684 | ||
| Pathodynamics of intoxication in rats and mice by enterotoxin of Clostridium perfringens type A | Q68022408 | ||
| Analysis of multiple antigenic determinants of Clostridium perfringens enterotoxin as revealed by use of different synthetic peptides | Q71683755 | ||
| Improvement of the systemic prime/oral boost strategy for systemic and local responses | Q73074996 | ||
| Determination of Functional Regions of Clostridium perfringens Enterotoxin Through Deletion Analysis | Q73732395 | ||
| Role of Tyr306 in the C-terminal fragment of Clostridium perfringens enterotoxin for modulation of tight junction | Q79433630 | ||
| A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide | Q82623408 | ||
| The effect of haptens on protein-carrier immunogenicity | Q87415852 | ||
| Low cost delivery of proteins bioencapsulated in plant cells to human non-immune or immune modulatory cells. | Q36445623 | ||
| Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells | Q36640081 | ||
| Fluid accumulation in mouse ligated intestine inoculated with Clostridium perfringens enterotoxin | Q36728605 | ||
| Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium | Q36940409 | ||
| Mapping of functional regions of Clostridium perfringens type A enterotoxin | Q36945527 | ||
| A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice | Q36951248 | ||
| Immunological commonalities and distinctions between airway and digestive immunity | Q37286785 | ||
| Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model | Q37473348 | ||
| Understanding the development and function of T follicular helper cells. | Q37728834 | ||
| Gut-associated lymphoid tissues for the development of oral vaccines | Q37914349 | ||
| Mutational analysis of ganglioside GM(1)-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras. | Q38291877 | ||
| FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities | Q38485652 | ||
| Claudin-related intestinal diseases. | Q38496976 | ||
| Development of an anti-claudin-3 and -4 bispecific monoclonal antibody for cancer diagnosis and therapy | Q38966594 | ||
| Metabolic changes during B cell differentiation for the production of intestinal IgA antibody | Q39006760 | ||
| Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis. | Q39457197 | ||
| The regulation of gut mucosal IgA B-cell responses: recent developments | Q39459081 | ||
| Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures. | Q39672122 | ||
| Mucosal vaccination using claudin-4-targeting | Q39713910 | ||
| A toxicological evaluation of a claudin modulator, the C-terminal fragment of Clostridium perfringens enterotoxin, in mice | Q39721561 | ||
| The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin | Q39813717 | ||
| Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis | Q40002338 | ||
| Sporulation and enterotoxin production by mutants of Clostridium perfringens | Q40098671 | ||
| Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin | Q40369090 | ||
| Internalization of cholera toxin by different endocytic mechanisms | Q40768765 | ||
| Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. | Q40925316 | ||
| Vital signs: incidence and trends of infection with pathogens transmitted commonly through food--foodborne diseases active surveillance network, 10 U.S. sites, 1996-2010 | Q41428597 | ||
| M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes | Q43260027 | ||
| Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera | Q45129797 | ||
| A novel strategy for the enhancement of drug absorption using a claudin modulator | Q45188971 | ||
| Economic burden from health losses due to foodborne illness in the United States. | Q45980309 | ||
| Novel vaccine development strategies for inducing mucosal immunity | Q24607533 | ||
| Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli | Q24642003 | ||
| Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting | Q24676979 | ||
| Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin | Q24683859 | ||
| World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis | Q26774950 | ||
| Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein | Q28141954 | ||
| Signals for sorting of transmembrane proteins to endosomes and lysosomes | Q29547469 | ||
| Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria | Q29619620 | ||
| Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin | Q30158051 | ||
| Antibodies enhance interaction of Vibrio cholerae with intestinal M-like cells | Q30478467 | ||
| Clostridium perfringens type A enterotoxin damages the rabbit colon | Q33603098 | ||
| Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery | Q33665038 | ||
| Keyhole limpet hemocyanin (KLH): a biomedical review | Q33764096 | ||
| Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine | Q33928456 | ||
| Luminal Bacteria Recruit CD103+ Dendritic Cells into the Intestinal Epithelium to Sample Bacterial Antigens for Presentation | Q33970555 | ||
| Killed oral cholera vaccines: history, development and implementation challenges | Q34087755 | ||
| Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. | Q34139462 | ||
| M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses | Q34194207 | ||
| Clostridium perfringens enterotoxin damages the human intestine in vitro | Q34194740 | ||
| A requirement for FcγR in antibody-mediated bacterial toxin neutralization | Q34243378 | ||
| Epidemiology of Foodborne Disease Outbreaks Caused byClostridium perfringens, United States, 1998–2010 | Q34326063 | ||
| Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex | Q34359173 | ||
| IgG subclasses and allotypes: from structure to effector functions | Q34368678 | ||
| Prediction of sequential antigenic regions in proteins | Q34377036 | ||
| Development and Application of a Mouse Intestinal Loop Model To Study the In Vivo Action of Clostridium perfringens Enterotoxin | Q35139274 | ||
| Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. | Q35192183 | ||
| C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine | Q35643907 | ||
| Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro | Q35787420 | ||
| Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination | Q35865115 | ||
| Regulation of plasma-cell development | Q36058417 | ||
| The role of adjuvants in the development of mucosal vaccines | Q36194084 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | poisoning | Q114953 |
| immunologic adjuvant | Q967453 | ||
| P304 | page(s) | 2320 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Enterotoxin | |
| P478 | volume | 9 |
Search more.